Reckitt Benckiser Prioritises Employee Safety as Iran War Enters Sixth Day
Household goods giant Reckitt Benckiser has declared that safeguarding its workforce in the Middle East is the immediate priority as the conflict involving Iran continues into a sixth day. Chief executive Kris Licht emphasised that it remains "too early" to determine whether supply chains and consumer prices will be affected by the rapidly evolving situation in the region.
Safety Measures Implemented Across Operations
The company, whose well-known brands include Strepsils throat sweets, Nurofen painkillers, and Dettol, has taken decisive action to protect its approximately 400 employees in the Middle East. A factory in Bahrain has been closed for safety reasons, and all regional staff have been instructed to work from home following the outbreak of hostilities last week.
Mr Licht told the Press Association: "Our overwhelming focus at the moment is on the safety and well-being of our employees and their families." He added, "It's significant for the people that work in these markets and live in these communities, and we want to do everything we can to support them and their well-being."
Supply Chain and Pricing Impacts Remain Uncertain
Regarding potential disruptions to supply routes and pricing, Mr Licht stated it was "too early to specify" the exact consequences. The comments come amid broader challenges for the consumer goods giant, which also cautioned that a weak global cold and flu season and difficult trading conditions in Europe would negatively impact performance at the start of 2026.
Financial Performance and Market Reaction
Despite reporting strong 2025 results, with pre-tax profits surging to £3.8 billion from £2.1 billion in 2024—driven by a 5% increase in like-for-like sales—Reckitt's shares fell by 6%. This decline reflected investor concerns over the gloomy outlook, which overshadowed the positive financial figures.
Underlying profits rose by 5.2% to £3.3 billion on a constant currency basis. However, sales in Europe dropped by 1.4%, attributed to lower demand for cold and flu treatments and a challenging consumer environment. The company warned that these tough trading conditions are expected to persist into 2026.
Analyst Perspective on Geopolitical Risks
Chris Beauchamp, chief market analyst at IG, noted that investors are particularly focused on the implications of the Middle East conflict for Reckitt. He remarked: "Reckitt's results couldn't come at a worse time, through no fault of the company of course. But investors will take all the assumptions in the outlook with a big pinch of salt, given that prices across the globe are likely to take a big lurch higher thanks to the situation in the Middle East."
This cautious stance highlights the broader uncertainty facing multinational corporations as geopolitical tensions escalate, with employee safety taking precedence over immediate financial assessments in volatile regions.
